XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Share-based Payment Arrangements (Tables)
 3 Months Ended
Mar. 27, 2021
Amounts Recognized in Financial Statements with Respect to Plans Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 
  
Thirteen Weeks Ended
 
 
  
March 27,

2021
 
  
March 28,

2020
 
Total cost of the Plans during the period
  
$
 4,029
 
  
$
 631
 
Amount of related income tax benefit recognized during the period
  
 
 (1,341
) 
  
 
 (873
) 
 
  
 
 
 
  
 
 
 
Net cost of the Plans during the period
  
$
2,688
 
  
$
 (242
) 
 
  
 
 
 
  
 
 
 
Summary of Information Regarding Stock Options
The following table summarizes information regarding the Company’s outstanding stock options under the Plans:
 
    
Number of
Options
     
Weighted Average
Exercise Price per
Share
     
Weighted Average
Remaining
Contractual

Term (years)
     
Aggregate Intrinsic
Value (000s)
  
Options outstanding at December 26, 2020
      17,650      $ 54.16                    
Exercised
      (5,280 )     $ 51.83                    
    
 
 
                             
Options outstanding at March 27, 2021
      12,370      $ 55.15        1.6      $ 1,411  
    
 
 
                             
Options exercisable at March 27, 2021
      12,370      $ 55.15        1.6      $ 1,411  
Restricted Stock Units (RSUs)  
Schedule of Information on Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
RSUs
     
Weighted Average

Grant Date

Fair Value
  
Outstanding at December 26, 2020
  
 
 183,213
 
  
$
 93.44
 
Granted
  
 
 45,707
 
  
$
 129.03
 
Vested shares
  
 
 (9,247
) 
  
$
 106.14
 
 
  
 
 
 
  
 
 
 
Outstanding at March 27, 2021
  
 
 219,673
 
  
$
 100.31
 
 
  
 
 
 
  
 
 
 
Non Vested Restricted Stock and Deferred Stock Units  
Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
 
  
Number of Shares

and Deferred Stock
Units
 
  
Weighted Average

Grant Date

Fair Value
 
Non-vested
at December 26, 2020
  
 
 60,440
 
  
$
 103.65
 
Granted
  
 
 18,078
 
  
$
 140.97
 
Vested
  
 
 (21,733
) 
  
$
 103.39
 
 
  
 
 
 
  
 
 
 
Non-vested
at March 27, 2021
  
 
 56,785
 
  
$
 115.63